Nido Biosciences, Inc. — Form D
Nido Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-08. The offering totals $46.0M, of which $18.4M was reported sold. Industry: Other.
Offering
- Filed: 2020-09-08
- Form: D
- Accession: 0001787670-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $46.0M
- Amount sold: $18.4M
- Remaining: $27.6M
- Investors: 6
- Date of first sale: 2020-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374988
Issuer
- Name: Nido Biosciences, Inc.
- CIK: 0001787670
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 650 E Kendall Street, Cambridge, MA, 02142
- Phone: 857-305-1833
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jamil Beg | Director | Cambridge, MA |
| Jacqueline Grant | Director | Durham, NC |
| Andrew Hedin | Director | Claymont, DE |
| Jamil Beg | Executive Officer | Cambridge, MA |
| Andrew Schwab | Director | BOSTON, MA |
| Elliot Ehrich | Director | Research Triangle Park, NC |
Other filings by this issuer (1)
More